Recurrent rheumatoid arthritis following allogeneic bone marrow transplant and seronegativity induced by rituximab therapy

Semin Arthritis Rheum. 2020 Oct;50(5):1055-1057. doi: 10.1016/j.semarthrit.2020.06.011. Epub 2020 Jul 2.

Authors

Charles J Bettag¹, Nicole M Orzechowski², William F C Rigby²

Affiliations

¹ Dartmouth Hitchcock Medical Center, Attn Dept of Medicine; Lebanon, New Hampshire 03756 United States. Electronic address: charles.j.bettag@hitchcock.org.
² Dartmouth Hitchcock Medical Center, Attn Dept of Medicine; Lebanon, New Hampshire 03756 United States.

PMID: 32911283
DOI: 10.1016/j.semarthrit.2020.06.011

No abstract available

MeSH terms

Antirheumatic Agents* / adverse effects
Arthritis, Rheumatoid* / drug therapy
Bone Marrow Transplantation
Hematopoietic Stem Cell Transplantation*
Humans
Rituximab / therapeutic use

Substances

Antirheumatic Agents
Rituximab